Factor IX

Results: 97



#Item
41Downloaded from http://pmj.bmj.com/ on March 1, [removed]Published by group.bmj.com

Downloaded from http://pmj.bmj.com/ on March 1, [removed]Published by group.bmj.com

Add to Reading List

Source URL: pmj.bmj.com

Language: English
42Measure Number Theme  HAE03

Measure Number Theme HAE03

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2014-08-12 08:04:41
43Microsoft PowerPoint - HAE[removed]Figure 1 [Compatibility Mode]

Microsoft PowerPoint - HAE[removed]Figure 1 [Compatibility Mode]

Add to Reading List

Source URL: www.hemophilia.org

Language: English - Date: 2014-04-22 11:47:01
44Microsoft Word - HAE[removed]2007_revised_manuscript

Microsoft Word - HAE[removed]2007_revised_manuscript

Add to Reading List

Source URL: www.hemophilia.org

Language: English - Date: 2014-04-22 11:47:01
45Death Receptors TRAIL-R1 and –R2

Death Receptors TRAIL-R1 and –R2

Add to Reading List

Source URL: pipelinereview.com

Language: English - Date: 2011-10-24 13:17:11
46Rodney M. Camire, Ph.D. Hematology Basic Research: Research most often conducted in a laboratory setting that is designed to enhance our scientific knowledge base (does not involve human subjects)

Rodney M. Camire, Ph.D. Hematology Basic Research: Research most often conducted in a laboratory setting that is designed to enhance our scientific knowledge base (does not involve human subjects)

Add to Reading List

Source URL: www.research.chop.edu

Language: English - Date: 2014-11-11 10:44:37
47Microsoft Word[removed]WFH Global Survey Report FINAL.docx

Microsoft Word[removed]WFH Global Survey Report FINAL.docx

Add to Reading List

Source URL: www1.wfh.org

Language: English - Date: 2014-11-26 14:14:10
48CDER Clinical Review Template

CDER Clinical Review Template

Add to Reading List

Source URL: www.fda.gov

Language: English
49Hemophilia Enhanced Specialty Discount Products Therapeutic Group  Label Name

Hemophilia Enhanced Specialty Discount Products Therapeutic Group Label Name

Add to Reading List

Source URL: www.ncdhhs.gov

Language: English - Date: 2014-10-08 15:19:43
50CLINICAL PHARMACOLOGY BLA REVIEW Division of Hematology Office of Blood Review & Research BLA: [removed]Product: BAX326 (RIXUBIS; Recombinant Factor IX) Indication: severe or moderately severe hemophilia B

CLINICAL PHARMACOLOGY BLA REVIEW Division of Hematology Office of Blood Review & Research BLA: [removed]Product: BAX326 (RIXUBIS; Recombinant Factor IX) Indication: severe or moderately severe hemophilia B

Add to Reading List

Source URL: www.fda.gov

Language: English